PMGC Holdings (ELAB) Enterprise Value (2023 - 2026)
PMGC Holdings' (ELAB) quarterly Enterprise Value came in at -$18.2 million in Q2 2026, down 203.96% year-over-year from $17.5 million in Q2 2025, and down 22.81% quarter-over-quarter from -$14.8 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Enterprise Value (2023 - 2026) Analysis & Trends
PMGC Holdings has disclosed Enterprise Value across 4 years of filings, most recently posting -$18.2 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 203.96% year-over-year to -$18.2 million; the TTM figure through Jun 2026 stood at -$18.2 million (down 203.96% YoY), while the FY2025 annual figure was -$5.9 million, down 53.0% from the prior year.
- Enterprise Value came in at -$18.2 million for Q2 2026 at PMGC Holdings, down from -$14.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $389.7 million in Q4 2023 to a low of -$18.2 million in Q2 2026.
- Average Enterprise Value over 4 years is $73.8 million, with a median of -$5.7 million recorded in 2025.
- Year-over-year, Enterprise Value sank 53.0% in 2025 and plunged 203.96% in 2026.
- Over 4 years, Enterprise Value stood at $389.7 million in 2023, then slumped by 100.99% to -$3.9 million in 2024, then slumped by 53.0% to -$5.9 million in 2025, then sank by 208.4% to -$18.2 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$18.2 million in Q2 2026, -$14.8 million in Q1 2026, and -$5.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.26 Bn | 193.27 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.66 Bn | 176.48 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn |
| 6 | Moderna | 53.55 Bn | 48.41 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.38 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 31.68 Bn | 30.40 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.20 Mn |
| Mar 31, 2026 | -14.82 Mn |
| Dec 31, 2025 | -5.90 Mn |
| Sep 30, 2025 | -8.23 Mn |
| Jun 30, 2025 | -5.99 Mn |
| Mar 31, 2025 | -5.67 Mn |
| Dec 31, 2024 | -3.86 Mn |
| Sep 30, 2024 | 25.29 Mn |
| Jun 30, 2024 | 219.05 Mn |
| Mar 31, 2024 | 239.92 Mn |
| Dec 31, 2023 | 389.69 Mn |